BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schaefer BC, Strominger JL, Speck SH. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 1997;17:364-77. [PMID: 8972217 DOI: 10.1128/MCB.17.1.364] [Cited by in Crossref: 58] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Woellmer A, Arteaga-Salas JM, Hammerschmidt W. BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression. PLoS Pathog 2012;8:e1002902. [PMID: 22969425 DOI: 10.1371/journal.ppat.1002902] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
2 Zhang L, Pagano JS. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency. Mol Cell Biol 1999;19:3216-23. [PMID: 10082588 DOI: 10.1128/MCB.19.4.3216] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 2.1] [Reference Citation Analysis]
3 Peng R, Moses SC, Tan J, Kremmer E, Ling PD. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter. J Virol 2005;79:4492-505. [PMID: 15767449 DOI: 10.1128/JVI.79.7.4492-4505.2005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
4 Schaefer BC, Paulson E, Strominger JL, Speck SH. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol Cell Biol 1997;17:873-86. [PMID: 9001242 DOI: 10.1128/MCB.17.2.873] [Cited by in Crossref: 58] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
5 Tempera I, Lieberman PM. Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 2010;1799:236-45. [PMID: 19853673 DOI: 10.1016/j.bbagrm.2009.10.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.5] [Reference Citation Analysis]
6 Padeira GL, Araújo C, Cordeiro AI, Freixo J, Martins CG, Neves JF. Case Report: Primary Immunodeficiencies, Massive EBV+ T-Cell Lympoproliferation Leading to the Diagnosis of ICF2 Syndrome. Front Immunol 2021;12:654167. [PMID: 33995370 DOI: 10.3389/fimmu.2021.654167] [Reference Citation Analysis]
7 Ichikawa T, Okuno Y, Sato Y, Goshima F, Yoshiyama H, Kanda T, Kimura H, Murata T. Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells. mSphere 2018;3:e00478-18. [PMID: 30487153 DOI: 10.1128/mSphere.00478-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
8 Countryman JK, Gradoville L, Miller G. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J Virol 2008;82:4706-19. [PMID: 18337569 DOI: 10.1128/JVI.00116-08] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
9 Thonur L, Russell GC, Stewart JP, Haig DM. Differential transcription of ovine herpesvirus 2 genes in lymphocytes from reservoir and susceptible species. Virus Genes 2006;32:27-35. [PMID: 16525732 DOI: 10.1007/s11262-005-5842-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
10 Fuentes-Pananá EM, Swaminathan S, Ling PD. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). J Virol 1999;73:826-33. [PMID: 9847397 DOI: 10.1128/JVI.73.1.826-833.1999] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
11 Anderson LJ, Longnecker R. An auto-regulatory loop for EBV LMP2A involves activation of Notch. Virology 2008;371:257-66. [PMID: 17980397 DOI: 10.1016/j.virol.2007.10.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wakeman BS, Izumiya Y, Speck SH. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential. J Virol 2017;91:e01434-16. [PMID: 27795414 DOI: 10.1128/JVI.01434-16] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
13 Guo R, Zhang Y, Teng M, Jiang C, Schineller M, Zhao B, Doench JG, O'Reilly RJ, Cesarman E, Giulino-Roth L, Gewurz BE. DNA methylation enzymes and PRC1 restrict B-cell Epstein-Barr virus oncoprotein expression. Nat Microbiol 2020;5:1051-63. [PMID: 32424339 DOI: 10.1038/s41564-020-0724-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ruf IK, Sample J. Repression of Epstein-Barr virus EBNA-1 gene transcription by pRb during restricted latency. J Virol 1999;73:7943-51. [PMID: 10482541 DOI: 10.1128/JVI.73.10.7943-7951.1999] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
15 Krithivas A, Young DB, Liao G, Greene D, Hayward SD. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 2000;74:9637-45. [PMID: 11000236 DOI: 10.1128/jvi.74.20.9637-9645.2000] [Cited by in Crossref: 154] [Cited by in F6Publishing: 115] [Article Influence: 7.0] [Reference Citation Analysis]
16 Kalla M, Göbel C, Hammerschmidt W. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites. J Virol 2012;86:447-58. [PMID: 22031942 DOI: 10.1128/JVI.06314-11] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
17 Bergbauer M, Kalla M, Schmeinck A, Göbel C, Rothbauer U, Eck S, Benet-Pagès A, Strom TM, Hammerschmidt W. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog 2010;6:e1001114. [PMID: 20886097 DOI: 10.1371/journal.ppat.1001114] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 6.4] [Reference Citation Analysis]
18 Salamon D, Takacs M, Ujvari D, Uhlig J, Wolf H, Minarovits J, Niller HH. Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus. J Virol 2001;75:2584-96. [PMID: 11222681 DOI: 10.1128/JVI.75.6.2584-2596.2001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
19 Verhoeven RJA, Tong S, Zong J, Chen Y, Tsao SW, Pan J, Chen H. NF-κB Signaling Regulates Epstein-Barr Virus BamHI-Q-Driven EBNA1 Expression. Cancers (Basel) 2018;10:E119. [PMID: 29659505 DOI: 10.3390/cancers10040119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
20 Murata T, Sugimoto A, Inagaki T, Yanagi Y, Watanabe T, Sato Y, Kimura H. Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation. Viruses 2021;13:2344. [PMID: 34960613 DOI: 10.3390/v13122344] [Reference Citation Analysis]
21 Yu KP, Heston L, Park R, Ding Z, Wang'ondu R, Delecluse HJ, Miller G. Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA. Proc Natl Acad Sci U S A 2013;110:8176-81. [PMID: 23625009 DOI: 10.1073/pnas.1301577110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
22 Paulson EJ, Speck SH. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol 1999;73:9959-68. [PMID: 10559309 DOI: 10.1128/JVI.73.12.9959-9968.1999] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
23 Zhang L, Pagano JS. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol 2000;74:1061-8. [PMID: 10627515 DOI: 10.1128/jvi.74.3.1061-1068.2000] [Cited by in Crossref: 71] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
24 Chen HS, Lu F, Lieberman PM. Epigenetic regulation of EBV and KSHV latency. Curr Opin Virol 2013;3:251-9. [PMID: 23601957 DOI: 10.1016/j.coviro.2013.03.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
25 Werner M, Ernberg I, Zou J, Almqvist J, Aurell E. Epstein-Barr virus latency switch in human B-cells: a physico-chemical model. BMC Syst Biol 2007;1:40. [PMID: 17764547 DOI: 10.1186/1752-0509-1-40] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
26 Hernando H, Shannon-Lowe C, Islam AB, Al-Shahrour F, Rodríguez-Ubreva J, Rodríguez-Cortez VC, Javierre BM, Mangas C, Fernández AF, Parra M, Delecluse HJ, Esteller M, López-Granados E, Fraga MF, López-Bigas N, Ballestar E. The B cell transcription program mediates hypomethylation and overexpression of key genes in Epstein-Barr virus-associated proliferative conversion. Genome Biol 2013;14:R3. [PMID: 23320978 DOI: 10.1186/gb-2013-14-1-r3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
27 Wakeman BS, Johnson LS, Paden CR, Gray KS, Virgin HW, Speck SH. Identification of alternative transcripts encoding the essential murine gammaherpesvirus lytic transactivator RTA. J Virol 2014;88:5474-90. [PMID: 24574412 DOI: 10.1128/JVI.03110-13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc Natl Acad Sci U S A 2010;107:850-5. [PMID: 20080764 DOI: 10.1073/pnas.0911948107] [Cited by in Crossref: 114] [Cited by in F6Publishing: 104] [Article Influence: 8.8] [Reference Citation Analysis]
29 Yoshioka M, Crum MM, Sample JT. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing. J Virol 2008;82:1679-87. [PMID: 18077719 DOI: 10.1128/JVI.02142-07] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
30 Salamon D, Takacs M, Schwarzmann F, Wolf H, Minarovits J, Niller HH. High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes. Virus Genes 2003;27:57-66. [PMID: 12913358 DOI: 10.1023/a:1025124519068] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
31 Tierney RJ, Kirby HE, Nagra JK, Desmond J, Bell AI, Rickinson AB. Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation. J Virol 2000;74:10468-79. [PMID: 11044091 DOI: 10.1128/jvi.74.22.10468-10479.2000] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
32 Elliott J, Goodhew EB, Krug LT, Shakhnovsky N, Yoo L, Speck SH. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. J Virol 2004;78:14062-5. [PMID: 15564516 DOI: 10.1128/JVI.78.24.14062-14065.2004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
33 Ruf IK, Moghaddam A, Wang F, Sample J. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates. J Virol 1999;73:1980-9. [PMID: 9971778 DOI: 10.1128/JVI.73.3.1980-1989.1999] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
34 Gray KS, Allen RD 3rd, Farrell ML, Forrest JC, Speck SH. Alternatively initiated gene 50/RTA transcripts expressed during murine and human gammaherpesvirus reactivation from latency. J Virol 2009;83:314-28. [PMID: 18971285 DOI: 10.1128/JVI.01444-08] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
35 Brink AA, Meijer CJ, Nicholls JM, Middeldorp JM, van den Brule AJ. Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders. Mol Pathol 2001;54:98-102. [PMID: 11322171 DOI: 10.1136/mp.54.2.98] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
36 Hughes DJ, Dickerson CA, Shaner MS, Sample CE, Sample JT. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency. J Virol 2011;85:11435-47. [PMID: 21865378 DOI: 10.1128/JVI.05158-11] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
37 Chau CM, Lieberman PM. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol 2004;78:12308-19. [PMID: 15507618 DOI: 10.1128/JVI.78.22.12308-12319.2004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
38 Frost TC, Gewurz BE. Epigenetic crossroads of the Epstein-Barr virus B-cell relationship. Curr Opin Virol 2018;32:15-23. [PMID: 30227386 DOI: 10.1016/j.coviro.2018.08.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]